Modum Bad
Vikersund, 3371, Norway
NCT Number: NCT02649114
The combination of EDs (ED) and post-traumatic sequelae of childhood trauma leads to significant impairment, suffering and represents a public health concern because it is frequently associated with role impairment, and is frequently under-treated. Considering the severity of these conditions, there is a need to develop more effective treatments that are tailored to the specific needs of these patients as no conclusion has been made about the treatment of choice. To improve treatment it is critically important to study treatment effects and the mechanism of these effects.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Vikersund, 3371, Norway
The overall aim of the current project is; (1) To build knowledge on how to best treat patients with ED with and without childhood trauma, (2) To develop our understanding about how change happens for these patients. The investigators will do this by compare two treatment models; (1) Compassion-Focused Therapy (CFT) and (2) Cognitive Behavioural Therapy (CBT), for EDs both treatment types delivered at Modum Bad Psychiatric Center, department of ED.
Patients included in this randomized controlled trial will receive treatment at Modum Bad, satisfy DSM-V criteria for ED and half of the patients will in addition have a history of childhood trauma. A total of 86 patients who have received either CFT or CBT are followed up two year after completion of the treatment. The study utilises a rich data set collected outcome measures at altogether 5 time points and process and sub-outcome measures at 13 time points. The investigators will take advantage of our established collaborative networks, both nationally and internationally and existing procedures, where all patients are assessed with the same clinical instruments based on current state-of-the-art methods.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Pre, weekly during treatment, post, 12-months followup, through study completion, an average of 1 year
Change from baseline in eating disorder symptoms on the dimensional scales on the Eating Disorder Examination questionnaire
Time frame: Time Frame: pre, post and 12-months followup, through study completion, an average of 1 year
Change from baseline to 12-months follow-up
Time frame: Pre, post and 12-months followup, through study completion, an average of 1 year
Change from baseline to 12-months follow-up
Time frame: Pretreatment, posttreatment and 12-months followup, through study completion, an average of 1 year
Change from baseline to 12-months follow-up
Time frame: Pretreatment, posttreatment and 12-months followup, through study completion, an average of 1 year
Change from baseline to 12-months follow-up
Time frame: Pretreatment, posttreatment and 12-months followup, through study completion, an average of 1 year
Change from baseline to 12-months follow-up
Time frame: Pretreatment, weekly during treatment, posttreatment and 12-months followupthrough study completion, an average of 1 year
Change from baseline to 12-months follow-up
Modum Bad
Other
Treatment of Eating Disorders With and Without Childhood Trauma: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02601495
Anxiety, Anxiety Disorders
View Trial DetailsNCT05206734
Acute Stress Disorder, Adjustment Disorders
London, United Kingdom
View Trial DetailsNCT04776304
Anger, Brain Concussion
Bethesda, Maryland, United States
View Trial DetailsNCT05651295
Anxiety, Anxiety Disorders
Columbus, Ohio, United States
View Trial Details